Metformin hydrochloride and Bladder cancer - from FDA reports


Summary

Bladder cancer is found among people who take Metformin Hydrochloride, especially for people who are male, 60+ old , have been taking the drug for 6 - 12 months, also take medication Actos, and have Type 2 diabetes . We study 14,740 people who have side effects while taking Metformin hydrochloride from FDA. Among them, 121 have Bladder cancer. Find out below who they are, when they have Bladder cancer and more.

What to expect?

If you take Metformin hydrochloride and have Bladder cancer, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Metformin hydrochloride and have Bladder cancer

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Metformin Hydrochloride

Metformin hydrochloride has active ingredients of metformin hydrochloride. It is often used in diabetes. (latest outcomes from Metformin hydrochloride 18,427 users)

Bladder Cancer

Bladder cancer has been reported by people with type 2 diabetes, diabetes, rheumatoid arthritis, high blood pressure, multiple sclerosis (latest reports from 15,643 Bladder cancer patients).

On Feb, 08, 2017

14,740 people reported to have side effects when taking Metformin Hydrochloride.
Among them, 121 people (0.82%) have Bladder Cancer


Number of reports submitted per year:

Could Metformin hydrochloride cause Bladder cancer?

Time on Metformin Hydrochloride when people have Bladder Cancer *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 27.27 %
  • 6 - 12 months: 27.27 %
  • 1 - 2 years: 18.18 %
  • 2 - 5 years: 18.18 %
  • 5 - 10 years: 9.09 %
  • 10+ years: 0.0 %

Gender of people who have Bladder Cancer when taking Metformin Hydrochloride *:

  • female: 25.53 %
  • male: 74.47 %

Age of people who have Bladder Cancer when taking Metformin Hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.22 %
  • 20-29: 1.22 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 13.41 %
  • 60+: 84.15 %

Top conditions involved for these people *:

  • Type 2 Diabetes (86 people, 71.07%)
  • Diabetes (18 people, 14.88%)
  • Dyslipidaemia (6 people, 4.96%)
  • High Blood Pressure (5 people, 4.13%)
  • Insulin-Requiring Type 2 Diabetes Mellitus (4 people, 3.31%)

Top co-used drugs for these people *:

  • Actos (77 people, 63.64%)
  • Januvia (17 people, 14.05%)
  • Amaryl (17 people, 14.05%)
  • Lantus (13 people, 10.74%)
  • Glucotrol (12 people, 9.92%)

Top other side effects for these people *:

  • Death (17 people, 14.05%)
  • Haematuria (11 people, 9.09%)
  • Urinary Tract Infection (6 people, 4.96%)
  • Oedema (5 people, 4.13%)
  • Chest Pain (5 people, 4.13%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Bladder cancer when taking Metformin hydrochloride?

Browse all side effects of Metformin hydrochloride

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Bladder cancer

Bladder cancer

Could your condition cause Bladder cancer

Bladder cancer

Related studies

Can you answer these questions?

More questions for: Metformin hydrochloride, Bladder cancer

You may be interested in these reviews

More reviews for: Metformin hydrochloride, Bladder cancer